⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 4, 2024Expert Opinion on Drug Safety

Antibody-drug conjugates-related interstitial lung diseases: data mining of the FAERS database

Zicheng Yu Haibin Zhu Xiaolan Liao

View at Publisher

Ask AI

Bookmark

Share

Abstract

Interstitial lung diseases (ILD) is a serious adverse event (AE) associated with antibody-drug conjugates (ADCs). This study aims to delve deeply into the signals of AE associated with ILD linked to ADCs.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yu et al. (2024) studied this question.

synapsesocial.com/papers/68e59566b6db643587530a18 https://doi.org/10.1080/14740338.2024.2401025

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Adverse Event of Interstitial Lung Disease in Patients Treated with Antibody-Drug Conjugates2025 · 10 citations
2Abstract PS1-05-08: Incidence and predictors of interstitial lung disease associated with antibody-drug conjugates in breast cancer: a systematic review and meta-analysisHuman Clinical Trial · 2026
3HER2‐Targeted Antibody–Drug Conjugates–Associated Interstitial Lung Disease: A Pharmacovigilance Study Based on FDA Adverse Event Reporting System DataOriginal Research · 2026
4Abstract PO4-12-06: Interstitial Lung Disease (ILD) in Sequential Antibody Drug Conjugate (ADC) use in patients with Metastatic Breast Cancer (MBC): A Multi-Institutional experience2024 · 2 citations
5Abstract 2398: Dissecting ADC pulmonary toxicity: A murine ADC-associated ILD model to guide and inform ADC discovery.Original Research · 2026

More related papers

Interstitial lung disease associated with novel anticancer agents in non-small cell lung cancer: a pharmacovigilance analysis using the FAERS database.2026
Abstract 5760: Intra-tissue quantitative analysis using LC/MS will determine the mechanisms of interstitial pneumonia induced by antibody-drug conjugates2024
Antineoplastic agent-associated interstitial lung disease in breast, ovarian, and prostate cancers: a pharmacovigilance study using the FDA adverse event reporting system2026

More from Expert Opinion on Drug Safety

Long-term safety of treatment of hemophilia A: a comprehensive reviewTue,
Tolerance of methotrexate co-administered with pegloticase in patients with uncontrolled gout: overview of the findings from the mirror RCTWed,